This article, lists the following clinical endpoints that all vaccines for COVID-19 should consider:

• SARS Cov-2 infection rate
• Asymptomatic infection rate
• Symptomatic infection (COVID-19) rate
• Non severe COVID-19 rate
• Severe COVID-19 rate

Link.
Link for the full text article.
doi: Link

To quote this article in bibliography:

Devan V. Mehrotra, Devan V, Holly E. Janes, Thomas R. Fleming, et al. “Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials." Annals of Internal Medicine (Epub ahead of print 22 October 2020). doi:10.7326/M20-6169

Join us in the social media!

Click here to subscribe to our Telegram Channel!

Click here to join to our Telegram Group for discussions

Monitor Image downloaded form iStock. A Standard License was purchased which allows the use of the file for any personal, business or commercial purposes that aren't otherwise restricted by the license.